This market research report includes a detailed segmentation of the global tissue heart valves market by product type (stented tissue heart valves and stentless tissue heart valves). It also outlines the market shares for key regions such as the Americas, APAC, Europe, and MEA. The leading vendors analyzed in this report are Medtronic, Edwards Lifesciences, St. Jude Medicals, and LivaNova.
Technavio’s market research analysts estimate the global tissue heart valves market, to grow at a CAGR of around 4% between 29016 and 2020. The prevalence of heart valve diseases such as atresia, stenosis, and congenital heart is on rise. People are opting for tissue heart valve replacement surgeries due to the implementation of minimally invasive (MI) procedures. MI procedures reduce blood loss and the need for blood transfusion and minimize pain and scarring. The Americas is the largest revenue-contributing region in the market, accounting for 41% of the overall market share.
The new market research report from Technavio provides a breakdown and analysis of the heart valves segments by technology.
“Physicians perform tissue heart valve replacement surgeries to treat people aged 60 and above who are at high-risk to develop complications. The implantation of these devices helps avoid frequent monitoring and tests to review their proper functioning. These devices also reduce the use of oral anticoagulation drugs for the management of bleeding complications,” says Brahadeesh Chandrasekaran, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
Stented tissue heart valves dominate the tissue heart valves market, occupying around 71% of the overall market share. These are made from bovine or porcine heart tissues and treated and mounted on an artificial stent. Medtronic’s Hancock series and Edwards Lifesciences’ PERIMOUNT are leading stented tissue heart valves in the market.
The leading vendors in the global tissue heart valves market are Medtronic, Edwards Lifesciences, St. Jude Medicals, and LivaNova. This market is consolidated and highly competitive. Vendors are extensively investing in research to develop safe and efficient products and gain regulatory approvals for their launch in the market.
A more detailed analysis is available in the Technavio report, Global Tissue Heart Valves Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
